Imagine a 3D printer where the object isn't built in empty air, but inside a special powder that acts like a flexible mold. This allows the machine to print complex shapes using materials that would normally collapse or leak, like soft silicones. It's like carving a sculpture inside a block of sand that supports the material until it's finished.
Traditional 3D printing is too slow, wastes too much material, and lacks compatibility with essential medical-grade materials like silicones. This limits the ability to create custom, biocompatible implants quickly.
A Dynamic Molding additive manufacturing process and a validated production line compliant with ISO 13485:2016 for medical devices.
If you are an implant manufacturer dealing with the need for patient-specific Class III devices — this project developed a Dynamic Molding process that creates ultra-realistic anatomical models and biocompatible implants. This ensures higher precision and adherence to MDR 2017/745 standards.
If you are a silicone producer dealing with the limitations of traditional 3D printing materials — this project developed a method to successfully produce silicone solutions. This allows for faster prototyping of soft-matter components without the waste of traditional molding.
If you are a provider dealing with long production times for custom medical gear — this project developed a hybrid additive manufacturing system that combines injection molding speed with 3D printing flexibility. This reduces production wastage and expands the range of compatible materials.
Based on available project data, specific pricing for the technology is not disclosed, although the project received an EU contribution of EUR 2,500,000 for development.
Yes, the project has validated a production line plan and established an environment complying with ISO 13485:2016 to manufacture devices from Class I to Class III.
Based on available project data, specific licensing terms are not mentioned, but the technology is developed by 3DEUS DYNAMICS SAS.
The production line is designed to comply with ISO 13485:2016 and the European Medical Device Regulation (MDR) 2017/745.
The project period runs from 2023-05-01 to 2025-10-31, with the current phase focusing on finalizing silicone development and accelerating commercial growth.
The project is led by a single partner, 3DEUS DYNAMICS SAS, a French SME. This 100% industry-led structure indicates a strong drive toward commercialization rather than academic research, focusing on direct market application in the medical sector.
Contact 3DEUS DYNAMICS SAS in France
Contact us to explore licensing or partnership opportunities with 3DEUS DYNAMICS.
